Compare Amylx Pharmaceuticals Inc (AMLX) vs AngloGold Ashanti Limited (AU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs AngloGold Ashanti Limited — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while AngloGold Ashanti Limited trades at $100.44 (market cap $49.28B). The key difference: AngloGold Ashanti Limited is far larger — about 18.7× Amylx Pharmaceuticals Inc's market cap, and AngloGold Ashanti Limited pays a 4.64% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | AU | |
|---|---|---|
Market Cap | $2.64B | $49.28B |
Sector | Health | Basic Materials |
52-Week High | $24.19 | $128.26 |
52-Week Low | $7.82 | $52.15 |
Enterprise Value | $2.39B | $48.29B |
Dividend Yield | — | 4.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About AngloGold Ashanti Limited
Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.
Read more on AU →
